report
one
sever
issu
rais
futur
studi
potenti
recombin
virusvector
vaccin
wild
type
pathogen
viru
strain
paper
present
assess
issu
formul
brighton
collabor
provid
appropri
context
understand
potenti
recombin
virusvector
vaccin
review
briefli
current
statu
viru
vector
vaccin
mechan
recombin
virus
experi
recombin
involv
live
attenu
vaccin
field
concern
rais
previous
literatur
regard
recombin
virusvector
vaccin
wild
type
viru
strain
present
discuss
major
variabl
could
influenc
recombin
virusvector
vaccin
circul
wild
type
viru
consequ
recombin
includ
intrins
recombin
properti
parent
viru
use
vector
sequenc
related
vector
wild
viru
viru
host
rang
pathogenesi
transmiss
replic
compet
vector
target
host
mechan
vector
attenu
addit
factor
potenti
affect
virul
circul
multipl
recombin
vector
target
popul
final
present
guid
principl
vector
design
test
intend
anticip
mitig
potenti
consequ
recombin
virusvector
vaccin
wild
type
pathogen
viru
strain
report
one
sever
issu
rais
futur
studi
potenti
recombin
virusvector
vaccin
wild
type
pathogen
viru
strain
paper
present
assess
issu
formul
brighton
collabor
provid
appropri
context
understand
potenti
recombin
virusvector
vaccin
review
briefli
current
statu
viru
vector
vaccin
mechan
recombin
virus
experi
recombin
involv
live
attenu
vaccin
field
concern
rais
previous
literatur
regard
recombin
virusvector
vaccin
wild
type
viru
strain
present
discuss
major
variabl
could
influenc
recombin
virusvector
vaccin
circul
wild
type
viru
consequ
recombin
includ
intrins
recombin
properti
parent
viru
use
vector
sequenc
related
vector
wild
viru
viru
host
rang
pathogenesi
transmiss
replic
compet
vector
target
host
mechan
vector
attenu
addit
factor
potenti
affect
virul
circul
multipl
recombin
vector
target
popul
final
present
guid
principl
vector
design
test
intend
anticip
mitig
potenti
consequ
recombin
virusvector
vaccin
wild
type
pathogen
viru
strain
brighton
collabor
global
nonprofit
scientif
independ
larg
volunt
research
network
creat
purpos
provid
reliabl
high
qualiti
intern
inform
guidelin
relev
vaccin
safeti
one
mani
work
group
within
brighton
collabor
viral
vector
vaccin
safeti
work
group
form
explor
safeti
issu
relev
virusvector
vaccin
world
health
organ
conven
inform
consult
character
qualiti
aspect
vaccin
base
live
viru
vector
one
section
report
review
regulatori
issu
live
viralvector
vaccin
includ
input
regul
repres
european
union
usa
specif
center
biolog
evalu
research
cber
unit
within
food
drug
administr
fda
china
health
canada
among
issu
rais
center
biolog
evalu
research
us
food
drug
administr
cberfda
recombin
live
virusvector
vaccin
circul
reactiv
latent
viru
could
theoret
gener
pathogen
strain
would
less
issu
vector
share
littl
homolog
circulatinglat
virus
risk
recombin
studi
possibl
nonclin
model
system
also
consid
clinic
studi
design
conven
addit
inform
consult
reinforc
concern
regard
recombin
within
vaccin
recipi
specif
report
consult
state
guidelin
character
viral
vector
base
vaccin
harmon
requir
follow
among
other
demonstr
stabil
inserttransgen
pcr
express
passag
vitro
andor
vivo
well
stabil
attenu
phenotyp
ie
investig
potenti
revers
recombin
replic
vaccin
recipi
us
food
drug
administr
european
medicin
agenc
publish
gener
guidanc
use
recombin
virusvector
vaccin
follow
report
specif
explor
issu
potenti
recombin
virusvector
vaccin
wild
type
pathogen
strain
viru
intent
conduct
exhaust
review
literatur
rather
provid
salient
exampl
guid
consider
issu
relev
topic
virusvector
vaccin
laboratorygener
chimer
virus
base
upon
replic
live
nonrepl
viru
vector
splice
gene
express
antigen
protein
target
pathogen
live
virusvector
vaccin
biolog
activ
produc
viru
progeni
vaccin
host
may
attenu
pathogen
either
mutat
vector
chimer
natur
vaccin
vector
use
heterolog
host
due
combin
factor
nonrepl
virusvector
vaccin
sever
attenu
undergo
complet
replic
cycl
infect
cell
administr
chimer
virusvector
vaccin
result
express
antigen
target
pathogen
induct
adapt
possibl
protect
immun
respons
time
write
two
virusvector
vaccin
approv
human
use
specif
imojev
dengvaxia
imojev
market
australia
thailand
immun
japanes
enceph
viru
infect
dengvaxia
approv
mexico
philippin
brazil
immun
dengu
fever
vaccin
base
live
yellow
fever
vaccin
viru
vector
gener
known
chimerivax
imojev
dengvaxia
gene
yellow
fever
viru
virion
structur
protein
e
replac
homolog
gene
japanes
enceph
viru
dengu
viru
respect
japanes
enceph
viru
dengu
viru
yellow
fever
viru
flavivirus
particular
chimera
repres
rel
subtl
exchang
antigen
among
close
relat
virus
numer
virusvector
vaccin
use
wide
rang
vector
target
varieti
differ
pathogen
variou
stage
research
develop
although
current
number
virusvector
vaccin
avail
human
use
small
varieti
viralvector
vaccin
avail
commerci
use
veterinari
practic
demonstr
promis
like
futur
use
viralvector
vaccin
human
recombin
describ
process
nucleic
acid
sequenc
two
differ
parent
virus
exchang
progeni
contain
sequenc
deriv
parent
rna
dna
virus
may
undergo
recombin
two
relat
genom
variant
viru
coinfect
cell
viral
system
three
differ
mechan
recombin
dictat
structur
viral
genom
dna
virus
recombin
occur
physic
breakag
rejoin
parent
dna
molecul
region
sequenc
homolog
fashion
similar
ident
process
bacteria
higher
organ
rna
virus
contain
segment
genom
gene
exchang
occur
primarili
reassort
individu
parent
genom
segment
progeni
virus
howev
intra
genic
recombin
also
report
segment
orthomyxovirus
reovirus
bunyavirus
recombin
observ
sever
singlestrand
rna
ssrna
viru
famili
repres
posit
neg
sens
genom
laboratori
wild
picornavirus
coronavirus
togavirus
retrovirus
posit
sens
ssrna
genom
display
rel
effici
recombin
frequenc
recombin
among
neg
sens
rna
virus
exclud
reassort
segment
genom
seem
rel
low
recombin
rna
virus
includ
retrovirus
thought
occur
replic
via
copi
choic
name
switch
rna
templat
replic
result
newli
synthes
genom
contain
sequenc
two
differ
parent
molecul
recombin
clearli
requir
coinfect
cell
two
differ
virus
circumst
lead
coinfect
vivo
clearli
understood
coinfect
could
theoret
result
infect
heterogen
popul
virus
simultan
overlap
serial
infect
differ
virus
infect
individu
harbor
persist
latent
reactiv
infect
differ
viru
nevertheless
recombin
among
virus
human
popul
clearli
occur
exemplifi
recent
studi
describ
interclad
recombin
varicella
zoster
viru
although
experi
virusvector
vaccin
human
limit
perspect
issu
recombin
virusvector
vaccin
wild
type
virus
inform
experi
tradit
live
attenu
human
viru
vaccin
virusvector
veterinari
vaccin
vaccin
virus
may
establish
longterm
reservoir
wild
recombin
attenu
vaccin
strain
circul
wild
type
virus
even
two
differ
live
attenu
vaccin
strain
document
specif
evid
exist
vaccinia
viru
use
vaccin
smallpox
erad
campaign
brazil
establish
durabl
reservoir
wild
caus
numer
cowpoxlik
infect
cattl
human
likewis
bovin
herpesviru
vaccin
may
establish
latent
reservoir
vaccin
anim
reactiv
may
spread
anim
numer
exampl
document
probabl
recombin
live
attenu
vaccin
virus
wild
virus
phylogenet
analysi
reveal
recombin
wild
circul
strain
newcastl
diseas
viru
ndv
avian
paramyxoviru
attenu
ndv
vaccin
strain
attenu
virus
contain
oral
polioviru
vaccin
frequent
recombin
relat
indigen
human
enteroviru
strain
produc
circul
vaccinederiv
poliovirus
cvdpv
caus
paralyt
diseas
reassort
rift
valley
fever
viru
strain
contain
wild
type
virusderiv
vaccin
virusderiv
genom
segment
isol
patient
receiv
needl
stick
injuri
vaccin
sheep
analysi
two
independ
isol
diseas
strain
pestiviru
bovin
viral
diarrhea
viru
bvdv
demonstr
strain
aros
via
homolog
nonhomolog
recombin
persist
bvdv
strain
vaccin
strain
result
evolut
strain
enhanc
pathogen
rel
parent
strain
analysi
strain
poxviru
myxoma
origin
isol
wild
rabbit
suggest
result
recombin
wild
myxoma
strain
vaccin
strain
genom
analysi
diseas
strain
porcin
reproduct
respiratori
syndrom
viru
prrsv
arteriviru
demonstr
recombin
attenu
prrsv
vaccin
strain
field
strain
addit
recombin
independ
deriv
attenu
avian
herpesviru
vaccin
strain
give
rise
circul
pathogen
recombin
virus
lastli
extraordinarili
evid
exist
retrovir
diseas
reticuloendotheliosi
introduc
avian
popul
via
contamin
develop
fowlpox
poxviru
marek
diseas
herpesviru
vaccin
circul
wild
integr
proviru
fowlpoxviru
genom
exampl
attest
potenti
genet
interact
vaccin
virus
virus
wild
contrast
noteworthi
million
dose
poxvirusvector
recombin
rabi
viru
vaccin
distribut
wild
unit
state
eurasia
western
europ
result
reproduc
reduct
elimin
wild
rabi
appli
report
recombin
wild
type
viru
strain
attest
util
recombin
vector
vaccin
furthermor
wide
varieti
viralvector
recombin
vaccin
routin
use
veterinari
practic
well
decad
record
evid
problem
result
recombin
wild
virus
thu
occurr
recombin
event
like
rare
unanticip
consequ
event
must
consid
develop
regul
alik
although
describ
recombin
occur
tradit
live
attenu
vaccin
virus
wild
type
virus
date
exampl
recombin
viru
vector
vaccin
strain
wild
type
viru
strain
outsid
laboratori
howev
least
two
separ
occas
possibl
recombin
viral
vaccin
vector
wild
type
viru
strain
debat
literatur
one
debat
relat
develop
chimerivax
base
vaccin
one
relat
develop
newcastl
diseas
viru
vector
debat
defin
central
concept
surround
issu
recombin
viral
vaccin
vector
wild
type
viru
strain
case
chimerivax
debat
issu
ultim
address
experiment
thu
provid
templat
safeti
assess
viral
vaccin
vector
discuss
detail
end
document
summari
wholli
feasibl
virusvector
vaccin
could
undergo
recombin
natur
occur
virus
produc
hybrid
virus
could
theoret
undesir
properti
affect
transmiss
virul
especi
given
entir
novel
natur
chimer
virus
prudenc
dictat
possibl
taken
account
design
virusvector
vaccin
medicin
regulatori
decis
made
basi
risk
benefit
consider
approach
primarili
taken
regul
toward
geneticallymodifi
organ
precautionari
principl
type
regulatori
decisionmak
riskbenefit
precautionari
principl
implor
prudenc
caution
part
develop
requir
provis
evid
support
decisionmak
subject
recombin
virusvector
vaccin
circul
wild
type
virus
compris
two
overlap
subtop
name
probabl
recombin
take
place
possibl
outcom
recombin
numer
variabl
affect
issu
probabl
imposs
quantifi
accur
given
exist
tool
knowledg
howev
major
variabl
could
influenc
recombin
virusvector
vaccin
circul
wild
type
viru
consequ
recombin
identifi
evalu
least
qualit
vaccin
develop
major
variabl
intrins
recombin
properti
parent
viru
use
vector
sequenc
related
vector
wild
viru
host
rang
pathogenesi
transmiss
replic
compet
vector
target
host
mechan
vector
attenu
addit
factor
potenti
affect
virul
variabl
consid
separ
follow
paragraph
note
differ
viru
famili
associ
differ
intrins
frequenc
recombin
intrins
properti
affect
probabl
recombin
take
place
gener
dna
virus
subject
rel
high
frequenc
recombin
although
rna
virus
gener
display
lower
recombin
frequenc
compar
dna
virus
retrovirus
posit
strand
rna
virus
picornavirus
coronavirus
togavirus
norovirus
readili
recombin
posit
strand
rna
virus
recombin
ineffici
recombin
among
neg
strand
rna
virus
demonstr
evolutionari
scale
frequenc
suffici
low
make
recombin
laboratori
condit
difficult
detect
segment
virus
display
extrem
high
rate
reassort
concern
express
live
attenu
influenza
vaccin
might
readili
reassort
circul
wild
type
strain
one
must
assum
vector
base
viru
famili
segment
genom
famili
prone
high
recombin
rate
would
also
prone
recombin
relat
wild
type
virus
opportun
recombin
aris
virus
given
famili
intrins
rate
recombin
cell
cultur
laboratori
anim
often
determin
experiment
recombin
among
relat
virus
wild
sometim
deduc
base
phylogenet
analys
intrins
recombin
properti
given
viru
taken
account
vaccin
vector
develop
dna
rna
virus
major
observ
recombin
event
occur
region
nucleic
acid
sequenc
homolog
parent
genom
thu
sequenc
alter
vector
reduc
homolog
wild
type
viru
theoret
reduc
probabl
recombin
vector
wild
type
viru
virus
attenu
chang
genom
sequenc
substitut
less
common
codon
sequenc
chang
silent
posit
origin
amino
acid
sequenc
gene
preserv
multipl
substitut
less
frequent
use
codon
codon
deoptim
result
loss
virul
attenu
also
achiev
introduct
mani
uncommon
combin
pair
codon
thu
chang
codon
pair
bia
vector
engin
fashion
theoret
reduc
frequenc
recombin
wild
type
homolog
altern
vector
intend
human
use
base
natur
occur
nonmammalian
virus
exampl
use
canarypox
viru
hiv
vaccin
vector
suffici
diverg
sequenc
homolog
mammalian
virus
probabl
recombin
vector
mammalian
viru
vaccin
host
lower
lastli
gross
alter
gene
arrang
vector
could
suppress
product
recombin
wild
type
viru
homolog
notabl
nonhomolog
recombin
among
virus
occur
albeit
rel
low
frequenc
manipul
influenc
homolog
recombin
theoret
affect
nonhomolog
recombin
event
furthermor
sequenc
homolog
irrelev
reassort
genom
segment
segment
virus
probabl
recombin
two
virus
directli
proport
probabl
cell
coinfect
two
parent
virus
consider
probabl
coinfect
turn
may
theoret
influenc
viru
host
rang
pathogenesi
ie
whether
infect
normal
acut
persist
chronic
latent
transmiss
consid
influenc
host
rang
use
avipoxviru
vector
human
nonavian
vertebr
limit
potenti
recombin
vector
wild
avipoxvirus
likewis
use
avian
newcastl
diseas
viru
ndv
vector
human
would
present
minim
opportun
coinfect
wild
type
avian
viru
thu
limit
opportun
recombin
contrast
use
human
adenoviru
vaccin
vector
carri
clear
potenti
genet
interact
vector
circul
human
adenovirus
consid
influenc
pathogenesi
one
would
expect
viru
wild
caus
latent
infect
target
popul
would
provid
greater
opportun
recombin
compar
viru
result
acut
infect
specif
exampl
herp
virus
propos
vaccin
vector
larg
fraction
human
popul
carri
sever
differ
herp
virus
latent
state
latent
wild
type
genom
could
theoret
provid
stabl
persist
popul
viru
genom
target
popul
could
recombin
vaccin
vector
comparison
vector
parent
usual
undergo
acut
infect
flaviviru
yellow
fever
opportun
recombin
would
rel
rare
transmiss
mechan
could
also
theoret
affect
probabl
recombin
viral
vaccin
vector
circul
viru
exampl
differ
speci
arthropodborn
flavivirus
exhibit
differ
observ
recombin
frequenc
natur
attribut
differ
mechan
vector
tick
mosquito
differ
host
vector
ecolog
among
differ
flavivirus
probabl
recombin
virusvector
vaccin
wild
viru
proport
viru
load
vaccin
individu
thu
limit
replic
compet
vector
vaccin
virtual
vaccin
vector
either
defect
viru
replic
natur
artifici
attenu
pathogen
target
popul
attenu
sometim
equat
reduc
viru
replic
henc
reduc
viru
load
reduc
opportun
recombin
natur
attenu
vector
compris
viru
specif
one
anim
speci
use
vector
vaccin
anoth
normal
nonpermiss
speci
exampl
includ
canarypox
viru
newcastl
diseas
viru
engin
use
human
describ
canarypox
particular
undergo
abort
infect
nonavian
cell
virtual
nullifi
opportun
recombin
vector
may
artifici
attenu
use
classic
method
serial
passag
vitro
modern
method
involv
engin
gene
delet
rearrang
modifi
vaccinia
ankara
provid
exampl
poxviru
vector
attenu
serial
passag
clade
b
gagpolnef
vaccin
provid
exampl
adenoviru
vector
artifici
attenu
delet
essenti
viral
regulatori
region
vesicular
stomat
viru
vector
attenu
rearrang
gene
order
viral
genom
specif
mechan
attenu
impact
consequ
recombin
vaccin
vector
wild
type
viru
specif
attenu
genet
link
transgen
express
revers
virul
seem
unlik
exampl
note
adenoviru
vector
transgen
encod
immun
antigen
may
insert
delet
region
recombin
event
restor
virul
vector
also
delet
transgen
convers
transfer
transgen
wild
type
viru
also
transfer
attenu
thu
theoret
recombin
virul
vaccin
vector
contrast
attenu
vaccinia
vector
mva
multipl
gene
mutat
delet
confer
attenu
transgen
express
one
site
recombin
wild
orthopox
viru
cowpox
viru
vaccinia
viru
monkeypox
viru
could
theori
either
repair
virul
mutat
transfer
transgen
wild
type
viru
background
gener
recombin
improv
replic
properti
rel
origin
vaccin
vector
also
leav
transgen
express
intact
vector
design
propos
incorpor
express
immun
modulatori
molecul
exampl
interleukin
stimul
otherwis
regul
immunogen
recombin
vaccin
howev
case
gene
may
act
virul
factor
exampl
model
poxviru
system
express
ectromelia
viru
natur
pathogen
mice
mousepox
viru
enhanc
pathogen
viru
confer
resist
recombin
viru
preexist
immun
infect
anim
theoret
recombin
vector
express
virul
factor
wild
type
viru
could
result
product
wild
viru
increas
virul
although
hypothet
possibl
recombin
two
live
recombin
vector
administ
popul
deserv
consider
two
exampl
provid
attenu
vaccinia
tiantan
use
china
smallpox
erad
assess
replicationcompet
vector
vaccin
replicationdefect
form
hepat
c
vaccin
similarli
replicationcompet
adenoviru
serotyp
test
human
vector
hiv
anthrax
caus
seriou
lower
respiratori
tract
diseas
militari
recruit
train
camp
nonrecombin
vaccin
prove
among
safest
vaccin
million
militari
recruit
vaccin
without
seriou
advers
experi
militari
continu
vaccin
recruit
today
vaccin
use
two
differ
vaccin
base
vector
popul
creat
opportun
recombin
could
gener
novel
viru
potenti
undesir
properti
practic
exampl
exist
tradit
attenu
veterinari
vaccin
recombin
two
independ
deriv
attenu
vaccin
infecti
laryngotrach
viru
herpesviru
affect
commerci
poultri
regener
pathogen
wild
type
viru
cite
vaccin
virus
wild
experi
chimerivax
may
serv
templat
analysi
role
recombin
develop
vector
vaccin
introduc
chimerivax
live
attenu
recombin
viru
platform
construct
live
attenu
yellow
fever
yf
vaccin
strain
envelop
protein
gene
yf
replac
correspond
gene
anoth
flaviviru
chimerivax
platform
use
develop
live
vaccin
dengu
virus
denv
west
nile
viru
wnv
japanes
enceph
viru
jev
concern
rais
recombin
chimerivax
vector
vaccin
wild
type
flavivirus
could
gener
novel
viru
enhanc
pathogen
concern
address
varieti
studi
includ
review
evid
interand
intratyp
recombin
among
flavivirus
wild
laboratori
test
recombin
among
flavivirus
deliber
construct
test
theoret
recombin
contain
heterolog
envelop
vaccin
antigen
wildtyp
vector
background
result
demonstr
intratyp
recombin
among
flavivirus
occur
evolutionari
scale
wild
littl
recombin
cell
cultur
substitut
heterolog
envelop
protein
virul
flaviviru
backbon
result
viru
properti
attenu
match
attenu
vaccin
vector
analysi
exist
vector
develop
new
vector
new
exist
studi
done
chimerivax
along
thorough
descript
distribut
host
rang
vaccin
wild
strain
effect
address
fundament
influenc
recombin
virusvector
vaccin
wild
strain
recommend
outlin
document
consist
recommend
us
food
drug
administr
european
medicin
agenc
potenti
recombin
circul
wildtyp
virus
address
develop
test
virusvector
vaccin
rather
attempt
prepar
specif
guidelin
vector
brighton
collabor
recommend
develop
take
respons
assess
potenti
recombin
virusvector
vaccin
wildtyp
circul
virus
take
account
issu
describ
specif
consid
evid
member
viru
genu
undergo
recombin
wild
experiment
condit
exampl
anim
model
cell
cultur
given
vector
design
mode
deliveri
assess
magnitud
opportun
recombin
clinic
scenario
given
vector
design
evalu
probabl
recombin
event
wild
viru
could
lead
viru
increas
pathogen
consid
potenti
mechan
wherebi
could
happen
cite
conduct
laboratori
studi
evalu
mechan
consid
vector
design
could
reduc
probabl
recombin
event
enhanc
safeti
leav
potenc
vector
larg
intact
develop
optim
system
recombin
strategi
detect
recombin
perhap
use
current
sensit
assay
detect
expect
virus
eg
pcr
infect
assay
new
broad
method
detect
novel
virus
eg
degener
pcr
massiv
parallel
sequenc
place
alreadi
exist
report
gener
conclus
investig
exist
brighton
collabor
templat
descript
vector
option
includ
detail
report
consid
